Jeffrey W. Sherman Insider Profile

4 Followers
Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Therapeutics, holds 169.78K shares in Xeris Pharmaceuticals (Ticker: XERS), holds 0.00 shares in Horizon Therapeutics (Ticker: HZNP), holds 64.26K shares in Strongbridge Biopharma (Ticker: SBBP).
tipranks
Jeffrey W. Sherman

Jeffrey W. Sherman
Horizon Therapeutics (HZNP)
EVP and Chief Medical Officer

Ranked #37,067 out of 99,218 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+26.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$553K
100.00%
0.00%
A breakdown of Jeffrey W. Sherman's holdings

Insider Roles

Xeris Pharmaceuticals
(XERS)
Director
Larimar Therapeutics
(LRMR)
Director
Roles that Jeffrey W. Sherman holds in companies

Most Profitable Insider Trade

Stock:
Xeris Pharmaceuticals
(XERS)
Rating:Informative Buy
Date:Nov 29, 2023 - Today
Return:+75.00%
The most profitable trade made by Jeffrey W. Sherman

Jeffrey W. Sherman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HZNP
Horizon Therapeutics
Oct 06, 2023
Uninformative Sell
27.35M
$0.00
SBBP
Strongbridge Biopharma
Oct 05, 2021
Uninformative Sell
36.59K
$128.52K
Xeris Pharmaceuticals
Jun 05, 2024
Director
Uninformative Buy
$553.48K
Larimar Therapeutics
Director
INSYQ
Insys Therapeutics
$137.80
List of latest transactions for each holding click on a transaction to see Jeffrey W. Sherman's performance on stock

Jeffrey W. Sherman insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey W. Sherman?
The percentage of profitable transactions made by Jeffrey W. Sherman is 50%.
    What is the average return per transaction made by Jeffrey W. Sherman?
    The average return per transaction made by Jeffrey W. Sherman is 26.40%.
      What stocks does Jeffrey W. Sherman hold?
      Jeffrey W. Sherman holds: HZNP, SBBP, XERS, LRMR, INSYQ stocks.
        What was Jeffrey W. Sherman’s latest transaction?
        Jeffrey W. Sherman latest transaction was an Uninformative Buy of ―.
          What was Jeffrey W. Sherman's most profitable transaction?
          Jeffrey W. Sherman’s most profitable transaction was an Informative Buy of XERS stock on November 29, 2023. The return on the trade was 75.00%.
            What is Jeffrey W. Sherman's role in Horizon Therapeutics?
            Jeffrey W. Sherman's role in Horizon Therapeutics is EVP and Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.